Is a complete AGEN research report available?

No complete published report is available for Agenus Inc. (AGEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Agenus Inc. (AGEN)

NASDAQ: AGEN · USD

$7.10

+0.45 (+6.8%)· Recorded snapshot

Market cap	319.6M
Revenue (ttm)	132.7M
Net income (ttm)	91.8M
EPS (ttm)	$2.51
Shares out	45M
P/E (trailing)	2.8x
Volume	622,911
Beta	1.32

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 132.7M
Net income (ttm): 91.8M
EPS (ttm): $2.51
P/E (trailing): 2.8x
Market cap: 319.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001098972
Company name	Agenus Inc.
Country	United States
Country code	US
CUSIP number	00847G804
Earnings date	2026-11-05
Earnings time	bmo
Employees	81
Employees change	-235
Employees growth	-74.37%
Enterprise value	$341.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1994
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2000-02-04
Is primary listing	Yes
Is SPAC	No
ISIN number	US00847G8042
Last 10-K release date	2026-03-16
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2024-04-12
Last stock split type	Reverse
Market cap	$319.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$7.10
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	AGEN
U.S. state	Massachusetts
Website	https://www.agenusbio.com

Metric

Value

Amount currency

USD

CIK code

0001098972

Company name

Agenus Inc.

Country

United States

Country code

CUSIP number

00847G804

Earnings date

2026-11-05

Earnings time

bmo

Employees

Employees change

-235

Employees growth

-74.37%

Enterprise value

$341.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1994

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2000-02-04

Is primary listing

Yes

Is SPAC

ISIN number

US00847G8042

Last 10-K release date

2026-03-16

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2024-04-12

Last stock split type

Reverse

Market cap

$319.6M

Market cap category

Micro-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$7.10

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

AGEN

U.S. state

Massachusetts

Website

https://www.agenusbio.com

Metric	Value
Earnings yield	35.29%
EV/Earnings	3.58x
EV/EBIT	9.16x
EV/EBITDA	8.1x
EV/Sales	2.48x
FCF / EV yield	-29.96%
FCF yield	-32.1%
Forward EV/Sales	3.54x
Forward P/S	3.31x
P/E ratio	2.83x
P/S ratio	2.31x
Price/EBITDA ratio	7.56x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

35.29%

EV/Earnings

3.58x

EV/EBIT

9.16x

EV/EBITDA

8.1x

EV/Sales

2.48x

FCF / EV yield

-29.96%

FCF yield

-32.1%

Forward EV/Sales

3.54x

Forward P/S

3.31x

P/E ratio

2.83x

P/S ratio

2.31x

Price/EBITDA ratio

7.56x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	27.04%
EBITDA margin	30.6%
Gross margin	113.61%
Operating margin	27.04%
Pretax margin	69.29%
Profit margin	69.34%
Profit per employee	$1.1M
Revenue per employee	$1.6M
ROA	12.53%
ROA (5Y)	-16.15%
ROCE	-60.69%
SBC / revenue	8.6%

Metric

Value

EBIT margin

27.04%

EBITDA margin

30.6%

Gross margin

113.61%

Operating margin

27.04%

Pretax margin

69.29%

Profit margin

69.34%

Profit per employee

$1.1M

Revenue per employee

$1.6M

ROA

12.53%

ROA (5Y)

-16.15%

ROCE

-60.69%

SBC / revenue

8.6%

Metric	Value
EPS growth quarters	12
EPS growth years	0
Gross profit growth	24.04%
Net income growth quarters	7
Net income growth years	2
Revenue growth	30.47%
Revenue growth (Q)	34.36%
Revenue growth (QoQ)	2.32%
Revenue growth 10Y	17.24%
Revenue growth 3Y	10.13%
Revenue growth 5Y	14.12%
Revenue growth quarters	5
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

24.04%

Net income growth quarters

Net income growth years

Revenue growth

30.47%

Revenue growth (Q)

34.36%

Revenue growth (QoQ)

2.32%

Revenue growth 10Y

17.24%

Revenue growth 3Y

10.13%

Revenue growth 5Y

14.12%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$4.7M
EBIT	$35.9M
EBITDA	$40.6M
EPS	$2.51
FCF per share	$-2.19
Financing cash flow	$35.7M
Free cash flow	$-98.5M
Free cash flow minus SBC	$-109.9M
Gross profit	$150.8M
Investing cash flow	$70.1M
Net borrowing	$-2.1M
Net cash flow	$7.3M
Net income	$91.8M
Operating cash flow minus SBC	$-109.9M
Operating income	$35.9M
Revenue	$132.7M
Stock-based compensation	$11.4M

Metric

Value

Capital expenditures

Depreciation and amortization

$4.7M

EBIT

$35.9M

EBITDA

$40.6M

EPS

$2.51

FCF per share

$-2.19

Financing cash flow

$35.7M

Free cash flow

$-98.5M

Free cash flow minus SBC

$-109.9M

Gross profit

$150.8M

Investing cash flow

$70.1M

Net borrowing

$-2.1M

Net cash flow

$7.3M

Net income

$91.8M

Operating cash flow minus SBC

$-109.9M

Operating income

$35.9M

Revenue

$132.7M

Stock-based compensation

$11.4M

Metric	Value
Altman Z-Score	-16.78
Book value per share	$-4.67
Debt / EBITDA	0.81
Goodwill	$24.1M
Interest coverage	0.6
Long-term assets	$93.9M
Long-term liabilities	$146.7M
Net cash (debt)	$-22M
Net cash / market cap	-7.16%
Net debt / EBITDA	0.54
Piotroski F-Score	4
Property, plant and equipment	$21.5M
Shareholders' equity	$-205.9M
Tangible book value	$-226M
Tangible book value per share	$-5.30
Total assets	$172.7M
Total cash	$18.7M
Total debt	$40.7M
Total liabilities	$378.5M
WACC	23.7%

Metric

Value

Altman Z-Score

-16.78

Book value per share

$-4.67

Debt / EBITDA

0.81

Goodwill

$24.1M

Interest coverage

0.6

Long-term assets

$93.9M

Long-term liabilities

$146.7M

Net cash (debt)

$-22M

Net cash / market cap

-7.16%

Net debt / EBITDA

0.54

Piotroski F-Score

Property, plant and equipment

$21.5M

Shareholders' equity

$-205.9M

Tangible book value

$-226M

Tangible book value per share

$-5.30

Total assets

$172.7M

Total cash

$18.7M

Total debt

$40.7M

Total liabilities

$378.5M

WACC

23.7%

Metric	Value
Asset turnover	0.74
Current assets	$78.8M
Current liabilities	$231.8M
Current ratio	0.34
Net working capital	$-140.6M
Quick ratio	0.32
Working capital	$-153M
Working capital turnover	-0.71

Metric

Value

Asset turnover

0.74

Current assets

$78.8M

Current liabilities

$231.8M

Current ratio

0.34

Net working capital

$-140.6M

Quick ratio

0.32

Working capital

$-153M

Working capital turnover

-0.71

Metric	Value
Buyback yield / dilution	-51%
Dividend yield	0%
Shareholder yield	-51%

Metric

Value

Buyback yield / dilution

-51%

Dividend yield

Shareholder yield

-51%

Metric	Value
10Y price change	-91.94%
10Y return CAGR	-22.12%
10Y total return	-91.79%
150-day SMA	$5.45
15Y price change	-87.45%
15Y return CAGR	-12.81%
15Y total return	-87.21%
1D price change	6.77%
1M price change	-18.27%
1M total return	-18.27%
1W price change	8.72%
1W total return	8.72%
1Y price change	68.19%
1Y return CAGR	68.25%
1Y total return	68.19%
20-day SMA	$7.05
200-day SMA	$4.91
20Y price change	-97.23%
20Y return CAGR	-16.34%
20Y total return	-97.18%
3M price change	13.87%
3M total return	13.87%
3Y price change	-55.41%
3Y return CAGR	-23.59%
3Y total return	-55.41%
50-day SMA	$7.62
50-day SMA vs 200-day SMA	50over200
52-week high	$10.31
52-week high date	2026-09-30
52-week low	$2.71
52-week low date	2026-02-05
5Y price change	-90.84%
5Y return CAGR	-37.77%
5Y total return	-90.67%
6M price change	70.66%
6M total return	70.66%
All-time high	$8,580.00
All-time high date	2000-02-07
All-time low	$1.38
All-time low date	2025-04-07
Average true range (ATR)	$0.53
Average volume	919.5K
Beta (1Y)	1.23
Beta (2Y)	1.98
Beta (5Y)	1.32
Change from 52-week high	-31.13%
Change from 52-week low	161.99%
Change from all-time high	-99.92%
Change from all-time low	405.8%
Change from open	8.56%
Day's gap	-1.65%
Dollar volume	$4.4M
High price	$7.10
Low price	$6.53
Monthly RSI	47.29
Open price	$6.54
Position in 52-week range	100%
Premarket change	-0.13%
Premarket close	$6.65
Premarket price	$6.64
Previous close	$6.65
Price vs 150-day SMA	28.05%
Price vs 20-day SMA	-0.94%
Price vs 200-day SMA	42.27%
Price vs 50-day SMA	-8.42%
Relative volume	0.68
RSI	48.48
Sharpe ratio	0.91
Sharpe ratio (3Y)	0.29
Sharpe ratio (5Y)	-0.02
Sortino ratio	1.84
Sortino ratio (3Y)	0.51
Sortino ratio (5Y)	0.02
Volume	622.9K
Weekly RSI	55.14
YTD price change	122.29%
YTD total return	122.29%

Metric

Value

10Y price change

-91.94%

10Y return CAGR

-22.12%

10Y total return

-91.79%

150-day SMA

$5.45

15Y price change

-87.45%

15Y return CAGR

-12.81%

15Y total return

-87.21%

1D price change

6.77%

1M price change

-18.27%

1M total return

-18.27%

1W price change

8.72%

1W total return

8.72%

1Y price change

68.19%

1Y return CAGR

68.25%

1Y total return

68.19%

20-day SMA

$7.05

200-day SMA

$4.91

20Y price change

-97.23%

20Y return CAGR

-16.34%

20Y total return

-97.18%

3M price change

13.87%

3M total return

13.87%

3Y price change

-55.41%

3Y return CAGR

-23.59%

3Y total return

-55.41%

50-day SMA

$7.62

50-day SMA vs 200-day SMA

50over200

52-week high

$10.31

52-week high date

2026-09-30

52-week low

$2.71

52-week low date

2026-02-05

5Y price change

-90.84%

5Y return CAGR

-37.77%

5Y total return

-90.67%

6M price change

70.66%

6M total return

70.66%

All-time high

$8,580.00

All-time high date

2000-02-07

All-time low

$1.38

All-time low date

2025-04-07

Average true range (ATR)

$0.53

Average volume

919.5K

Beta (1Y)

1.23

Beta (2Y)

1.98

Beta (5Y)

1.32

Change from 52-week high

-31.13%

Change from 52-week low

161.99%

Change from all-time high

-99.92%

Change from all-time low

405.8%

Change from open

8.56%

Day's gap

-1.65%

Dollar volume

$4.4M

High price

$7.10

Low price

$6.53

Monthly RSI

47.29

Open price

$6.54

Position in 52-week range

100%

Premarket change

-0.13%

Premarket close

$6.65

Premarket price

$6.64

Previous close

$6.65

Price vs 150-day SMA

28.05%

Price vs 20-day SMA

-0.94%

Price vs 200-day SMA

42.27%

Price vs 50-day SMA

-8.42%

Relative volume

0.68

RSI

48.48

Sharpe ratio

0.91

Sharpe ratio (3Y)

0.29

Sharpe ratio (5Y)

-0.02

Sortino ratio

1.84

Sortino ratio (3Y)

0.51

Sortino ratio (5Y)

0.02

Volume

622.9K

Weekly RSI

55.14

YTD price change

122.29%

YTD total return

122.29%

Metric	Value
Float	40.2M
Float percentage	89.35%
Shares change (QoQ)	7.97%
Shares change (YoY)	51%
Shares held by insiders	1.48%
Shares held by institutions	40.06%
Shares outstanding	45M
Short % of float	16.95%
Short % of shares	15.15%
Short ratio	6.5 days

Metric

Value

Float

40.2M

Float percentage

89.35%

Shares change (QoQ)

7.97%

Shares change (YoY)

51%

Shares held by insiders

1.48%

Shares held by institutions

40.06%

Shares outstanding

45M

Short % of float

16.95%

Short % of shares

15.15%

Short ratio

6.5 days

Agenus Inc. (AGEN)

Price

Financial snapshot

Fair-value bridge

Latest news · AGEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AGEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AGEN

Frequently asked questions